Twist Bioscience Corporation
TWST
$55.95
-$0.26-0.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 19.31% | 16.89% | 16.88% | 17.91% | 23.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.31% | 16.89% | 16.88% | 17.91% | 23.23% |
| Cost of Revenue | 14.60% | 8.40% | 3.65% | -3.10% | 5.28% |
| Gross Profit | 24.10% | 25.99% | 32.97% | 45.44% | 49.04% |
| SG&A Expenses | 19.50% | 24.15% | 19.97% | 11.58% | 14.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.18% | 10.73% | 6.78% | 0.57% | 8.18% |
| Operating Income | 6.98% | 5.03% | 16.95% | 31.53% | 14.99% |
| Income Before Tax | -12.32% | 3.95% | 22.65% | 124.11% | 13.28% |
| Income Tax Expenses | -75.43% | 160.82% | 367.71% | 0.00% | -49.28% |
| Earnings from Continuing Operations | -11.93% | 3.44% | 21.69% | 123.83% | 13.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.93% | 3.44% | 21.69% | 123.83% | 13.55% |
| EBIT | 6.98% | 5.03% | 16.95% | 31.53% | 14.99% |
| EBITDA | 8.24% | 5.45% | 16.12% | 32.60% | 12.88% |
| EPS Basic | -8.21% | 6.46% | 24.11% | 123.10% | 16.26% |
| Normalized Basic EPS | 9.19% | 6.94% | 25.05% | 32.27% | 16.01% |
| EPS Diluted | -8.21% | 6.46% | 24.28% | 122.42% | 16.26% |
| Normalized Diluted EPS | 9.19% | 6.94% | 25.05% | 33.58% | 16.01% |
| Average Basic Shares Outstanding | 3.44% | 3.24% | 3.19% | 3.18% | 3.24% |
| Average Diluted Shares Outstanding | 3.44% | 3.24% | 3.19% | 5.19% | 3.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |